Correlation Between Dermata Therapeutics and Zevra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Zevra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Zevra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Zevra Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Zevra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Zevra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Zevra Therapeutics.
Diversification Opportunities for Dermata Therapeutics and Zevra Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dermata and Zevra is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Zevra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zevra Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Zevra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zevra Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Zevra Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Zevra Therapeutics
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.66 times more return on investment than Zevra Therapeutics. However, Dermata Therapeutics is 1.66 times more volatile than Zevra Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Zevra Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 124.00 in Dermata Therapeutics on November 29, 2024 and sell it today you would lose (5.00) from holding Dermata Therapeutics or give up 4.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. Zevra Therapeutics
Performance |
| Timeline |
| Dermata Therapeutics |
| Zevra Therapeutics |
Dermata Therapeutics and Zevra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Zevra Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and Zevra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Zevra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zevra Therapeutics will offset losses from the drop in Zevra Therapeutics' long position.| Dermata Therapeutics vs. Beam Therapeutics | Dermata Therapeutics vs. Editas Medicine | Dermata Therapeutics vs. Caribou Biosciences | Dermata Therapeutics vs. Verve Therapeutics |
| Zevra Therapeutics vs. Transcode Therapeutics | Zevra Therapeutics vs. Fortress Biotech | Zevra Therapeutics vs. Akebia Ther | Zevra Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |